Posted August 2nd, 2021 for Evotec
Hamburg, Germany, 02 August 2021: Evotec SE (Frankfurt Stock Exchange; EVT, MDAX/TecDAX, ISIN: DE0005664809, WKN 566480) announces that it confidentially submitted a Registration Statement on Form F-1 (“Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) for a proposed offering and sale in the United States of shares of Evotec represented by American Depositary Shares ( ADSs ). The Registration Statement has not yet become effective and the final number of ADSs to be offered and their price have not yet been determined. Evotec’s shares are listed on the regulated market of the Frankfurt Stock Exchange in Germany with additional admission obligations of the Prime Standard Segment. Evotec will seek a secondary listing of the ADSs on the Nasdaq Global Select Market in the United States under the ticker symbol “EVO”. The new shares underlying the ADSs will be issued from E
Silicon Labs Announces Commencement of Modified Dutch Auction Tender Offer to Purchase Up to $1 0 Billion of its Common Stock
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Investegate |MaxCyte, Inc Announcements | MaxCyte, Inc : Closing of Offering
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Orphazyme A/S of Class Action Lawsuit and Upcoming Deadline
law.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from law.com Daily Mail and Mail on Sunday newspapers.